• SENSEX 75,476.89
    -818.47 (--1.07%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • Infosys
    1,451.50 1,359.10(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • TCS
    3,307.55 3,396.10(%)
  • Vodafone Idea
    7.85 6.60(%)
  • Jio Financial
    222.30 198.60(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Angel One
    2,317.80 1,942.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sun Pharma Advanced Research Company Ltd Miscellaneous

  • Sun Pharma
  • BSE Code : 27675.0
  • ISIN : INE232I01014
150.00 4 (3.02%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    147.19

  • Today’s High

    153.00

  • Open

    147.19

  • Perv Close

    145.60

  • 52W Low

    109.30

  • 52W High

    472.80

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    4,867.82

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.85

  • Debt-Equity Ratio

    3.02

  • AGM Date

    03-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    4,867.82

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    32.45

  • BV (₹)

    3.80

  • Sales( ₹ in Cr.)

    75.55

  • NP (in Cr.)

    -388.69

  • NP Var(%)

    -75.0

  • Div%

    0.0

  • CPS (₹)

    -11.60

  • EPS (₹)

    -12.00

  • Traded Value (₹ in Lakhs)

    4,866.20

  • 52 Week High

    472.80

  • 52 Week Low

    109.30

  • Price BSE

    150.0

  • Price NSE

    150.00

  • Market Capital( in Cr.)

    4,866.20

  • P/C Ratio

    -12.90

  • P/E Ratio

    -12.50

  • Price Vs.BV

    -12.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 75.55 238.78 137.25 252.96 76.81 182.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.55 238.78 137.25 252.96 76.81 182.87
Other Income 29.47 10.88 6.84 5.41 9.76 13.51
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 105.01 249.66 144.09 258.37 86.58 196.38
EXPENDITURE :
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power & Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 118.53 107.00 98.31 91.59 93.09 81.06
Other Manufacturing Expenses 7.03 4.87 2.41 3.48 6.81 8.80
Selling & Administrative Expenses 292.27 289.71 183.33 242.71 223.29 68.70
Miscellaneous Expenses 7.03 4.87 2.41 3.48 6.81 8.80
Less : Pre-operative Expenses Capitalised :
Total Expenditure 493.12 472.24 347.49 409.51 398.98 341.81
Operating Profit 33.37 29.15 21.68 31.98 39.71 163.07
Interest 1.66 7.63 13.33 10.65 2.67 0.09
Gross Profit -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Depreciation 12.13 11.77 10.16 10.92 9.48 7.55
Profit Before Tax -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Extraordinary Items -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Adjusted Net Profit -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -388.11 -222.58 -203.40 -151.14 -312.40 -145.43
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -11.96 -7.82 -7.73 -5.77 -11.92 -5.69
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    65.67%

  • Public Share Holding

    34.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 142,106,094 43.79 142,104,894 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 65,440,885 20.17 65,440,885 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 5,413,194 1.67 5,413,194 2
Trusts 154,922 0.05 154,922 1
Others 0 0.00 0 0
Sub Total 213,115,095 65.67 213,113,895 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 668 0.00 668 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 653 0.00 569 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,233,425 2.23 7,232,225 61
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 18,868 0.01 18,868 1
Mutual Funds / UTI 1,639,134 0.51 1,639,034 13
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 403,241 0.12 403,241 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,295,989 2.86 9,294,605 90
2] Non Institution
Bodies Corporate 24,104,806 7.43 24,093,072 879
Clearing Members 3,781 0.00 3,781 8
Directors of their Relatives 751,861 0.23 751,861 11
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 9,600 0.00 9,600 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,371,739 0.73 2,362,035 1,902
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,219,173 0.68 2,219,173 2,905
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,290,252 5.33 17,290,252 17
Individuals holding nominal share capital up to Rs. 1 lakh 43,998,261 13.56 43,460,819 125,197
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 7,048 0.00 7,048 5
Others 11,352,389 3.50 11,352,389 4
Sub Total 102,110,504 31.46 101,551,578 130,930
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 324,521,588 100.00 323,960,078 131,034

Company Background

Sun Pharma Advanced Research Company LtdMiscellaneous

  • Sun Pharma Advanced Research Company Ltd
  • BSE Code : 27675.0
  • ISIN : INE232I01014

  • Incorporation Year

    2006

  • Registered Office

    Sun Pharma Advanced Res Centre
    Akota Road Akota, Vadodara,
    Gujarat-390020

  • Telephone

    91-265-2330815/2339257

  • FAX

    91-265-2354897

  • Chairman

    Dilip S Shanghvi

  • Managing Director

  • Company Secretary

    Kajal Damania.

  • Auditor

    S R B C & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sun Pharma Advanced Research Company Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SPARC 149.95 105.01 75.55 -12.44 0.00
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92